bibliographicCitation |
Zhang HL, Ye DW, Yao XD, Dai B, Zhang SL, Shen YJ, Zhu Y, Zhang W. Docetaxel plus prednisone versus mitoxantrone plus prednisone for metastatic hormone-refractory prostate cancer in Chinese patients: experience of a single center. Urol Int. 2007;79(4):307–11. doi: 10.1159/000109714. PMID: 18025847. |